08/29/2012
Alexandra J. Lansky, MD; Krishnankutty Sudhir, MD, PhD; Takaaki Isshiki, MD; Tadashi Kikuchi, MD, PhD; Hiroshi Nonogi, MD, PhD; Keiichi Igarashi, MD; Kenshi Fujii, MD; Kumiko Saito, MS, MPH; Hiroshi Fujita, MD; Shigeru Nakamura, MD; Shigeru Saito, MD; Kazuaki Mitsudo, MD; Masato Nakamura, MD; Takeshi Kimura, MD; Hauro Hirayama, MD, PhD; Gregg W. Stone, MD, FACC, FSCAI; Yasuhiro Honda, MD; Peter J. Fitzgerald, MD, PhD; Katsuhisa Waseda, MD, PhD
Abstract: To address safety concerns with first-generation drug-eluting stents (DESs), the everolimus-eluting stent (EES) has been developed as a second-generation DES. The study aim was to: (1) demonstrate that use of the EES in Japanese...
Abstract: To address safety concerns with first-generation drug-eluting stents (DESs), the everolimus-eluting stent (EES) has been developed as a second-generation DES. The study aim was to: (1) demonstrate that use of the EES in Japanese...
Abstract: To address safety...